To determine if the clinical impact of MYC DNA amplification or mRNA expression differs by breast cancer subtype, we analyzed the distribution of MYC DNA amplified and mRNA high expressing tumors in each breast cancer subtype. The gene discussed is MYC; the disease is breast cancer.